跳至主要内容
临床试验/NCT00987883
NCT00987883Unknown不适用

Malnutrition and Its Impact on the Perioperational Hospitalization Cost: A Prospective, Cohort Study on Gastroenterological Cancer Patients

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Cost

研究概览

简要总结

Undernutrition is a state marked by energy and/or protein intake deficiency or mal-absorption, and is often described as protein energy malnutrition (PEM). Malnutrition is common in hospitalized patients worldwide. The prevalence of malnutrition in hospitalized patients range from 20% - 50%, depends on the varieties of diseases, health system, population and assessment tools. It is well documented in Western countries that malnutrition affects clinical outcomes negatively. Compared with well-nourished patients, patients with malnutrition stay longer in hospitals and related cost is significantly higher.

There is increasing evidence which indicates that appropriate nutrition support (e.g., standardized nutrition screening procedures, delivering nutrients with appropriate path, etc) may improve clinical outcome on malnutrition, along with cost saving.

To date, there is no study to document specifically the impact of malnutrition and related nutrition support on the health economics in China. Considering China now is on its way to establish public health security system and a diagnosis-related grouping system, the understanding of the cost effectiveness of nutrition support under the current clinical conditions is crucial.

This study aims to investigate the prevalence of perioperational malnutrition in gastroenterological cancer patient, the nutrition support status and related health economic effects.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older
  • With gastroenterological cancer
  • Will receive resectional operation
  • Consent informed

排除标准

  • With severly cardiac, pulmonary, liver or renal disease
  • With endocrine or metabolic disease
  • With dyslipidemia
  • Without consent

结局指标

主要结局

Cost

时间窗: 30 days after operation

次要结局

  • Length of hospitalization(30 days after operation)
  • Mortality(30 days after operation)
  • Infectious morbidity(30 days after operation)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验